Skip to main content
logo
Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
2.420
+0.030 (1.26%)
At close: Aug 6, 2026, 4:00 PM EDT
2.448
+0.028 (1.15%)
Pre-market: Aug 7, 2026, 7:00 AM EDT

Atossa Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31.7241.371.0888.46110.89136.38
Cash & Short-Term Investments
31.7241.371.0888.46110.89136.38
Cash Growth
-51.29%-41.90%-19.64%-20.23%-18.69%244.79%
Other Receivables
----0.741.07
Total Trade Receivables
----0.741.07
Other Current Assets
4.954.323.373.766.563.79
Total Current Assets
36.6745.6274.4692.22118.2141.24
Long-Term Investments
---1.714.7-
Other Long-Term Assets
1.281.991.992.320.640.02
Total Assets
37.9447.6176.4496.25123.53141.26
Accounts Payable
2.574.290.680.812.971.72
Accrued Expenses
3.752.872.782.632.581.39
Other Current Liabilities
1.141.11.511.80.020.02
Total Current Liabilities
7.468.264.975.245.573.13
Total Liabilities
7.468.264.975.245.573.13
Common Stock
1.551.551.5522.7922.7922.79
Treasury Stock
-1.48-1.48-1.48-1.48--
Additional Paid-in Capital
286.56285.84283.19255.99251.37244.58
Retained Earnings
-256.15-246.56-211.79-186.29-156.19-129.23
Shareholders' Equity
30.4939.3571.4891.02117.96138.14
Total Liabilities & Equity
37.9447.6176.4496.25123.53141.26
Net Cash (Debt)
31.7241.371.0888.46110.89136.38
Net Cash Growth
-51.29%-41.90%-19.64%-20.23%-18.69%244.94%
Net Cash Per Share
3.684.808.4710.5213.1417.49
Book Value
30.4939.3571.4891.02117.96138.14
Book Value Per Share
3.544.578.5210.8313.9717.72
Tangible Book Value
30.4939.3571.4891.02117.96138.14
Tangible Book Value Per Share
3.544.578.5210.8313.9717.72
SEC Filings: 10-K · 10-Q